Medicare National Coverage Determinations (NCD) Manual (Pub. 100-03), Ch. 1 § 50.5
Oxygen Treatment of Inner Ear/Carbon Therapy
50.5 - Oxygen Treatment of Inner Ear/Carbon Therapy
(Rev. 1, 10-03-03)
CIM 35-29
Not Covered
Oxygen (95 percent) and carbon dioxide (5 percent) inhalation therapy for inner ear
disease, such as endolymphatic hydrops and fluctuant hearing loss, is not reasonable and
necessary. The therapeutic benefit deriving from this procedure is highly questionable.